 of 76%. Goldman330
published results of a prospective trial comparing the effi-

JOURNAL OF VASCULAR SURGERY
May Supplement 2011

cacy of two liquid sclerosants, polidocanol and STS, and
both were used to treat varicose and telangiectatic veins. All
patients had an average of 70% improvement, and 70% to
72% were satisfied in all